What type of product is Clevatess?

What type of product is Clevatess?

Clevatess is a prescription medication that belongs to a class of drugs known as GLP-1 receptor agonists, specifically designed for weight management in adults with obesity or overweight conditions. This innovative pharmaceutical product contains the active ingredient liraglutide, which works by mimicking hormones that regulate blood sugar and slow gastric emptying, ultimately helping patients feel fuller for longer periods.

How Clevatess Works

As a GLP-1 receptor agonist, Clevatess activates receptors in the brain that control appetite and food intake. The medication is administered through a once-daily subcutaneous injection, typically in the abdomen, thigh, or upper arm. This delivery method ensures consistent absorption and effectiveness throughout the day.

Key Product Features

Medical Classification: Clevatess falls under the category of anti-obesity medications, specifically designed for chronic weight management rather than short-term weight loss solutions.

Target Population: The product is indicated for adults with a body mass index (BMI) of 30 kg/m² or greater, or those with a BMI of 27 kg/m² or greater who have at least one weight-related health condition such as high blood pressure or type 2 diabetes.

Administration and Usage

Clevatess comes as a pre-filled injection pen that patients can self-administer after proper training from healthcare providers. The medication is typically started at a lower dose and gradually increased to minimize potential side effects and improve tolerance.

Clinical Significance

This prescription weight management product represents a significant advancement in obesity treatment, offering patients a medically supervised approach to sustainable weight loss when combined with a reduced-calorie diet and increased physical activity.

If you're considering Clevatess for weight management, consult with your healthcare provider to determine if this medication aligns with your specific health needs and weight loss goals.